Law Daily Report

GSK buys full rights to make COVID, influenza vaccines from CureVac

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 44 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 63%

Curevac News

Avian Influenza,Influenza,Messenger RNA

The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing...

- GSK has bought from CureVac , the full rights to develop and manufacture vaccine candidates for influenza and COVID-19 that use messenger RNA technology for up to 1.05 billion euros , it said on Wednesday.

As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development. A teenager who crashed a BMW SUV while driving 190 km/h, causing the deaths of her sister and a friend, was sentenced Tuesday during an emotional hearing that saw many in the courtroom, including the judge and lawyers, struggle to contain their emotions. The girl, who was 16 years old at the time of the incident, will spend two years on probation under conditions that include community service. She is also prohibited from driving for five years.

2 Missing Ga. Firefighters Who'd Been High School Sweethearts Are Found Dead Days After Woman Keyed Man's CarJustice Thomas Goes Rogue on Trump Immunity Case, Pushes to Ditch Special Prosecutors

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 47. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

GSK stock sinks after court allows Zantac lawsuits to proceedShares of Britain-based pharmaceutical company GSK plc (GSK) — formerly known as GlaxoSmithKline — are sliding in pre-market trading and into Monday's...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »

GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside others including Sanofi, must face trials over whether...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »

GSK Plunges as Drugmaker Must Face Zantac Cases in DelawareGSK Plc shares slumped in the wake of a court ruling that the UK drugmaker, alongside others including Sanofi, must face trials over whether the former heartburn treatment Zantac causes cancer.
Source: BNNBloomberg - 🏆 83. / 50 Read more »